To examine whether human ATP-binding cassette (ABC) transporters play a role in the detoxification of plant alkaloid berberine, we investigated berberine transport using multidrug resistance protein1 (MDR1) and multidrug resistance-associated protein1 (MRP1). Cells expressing MDR1 or MRP1 accumulated less berberine. Berberine accumulation depended on the cellular ATP level, and was reversed by typical inhibitors of MDR1, suggesting that human MDR1 and MRP1 directly efflux berberine as their substrate.
Berberine is a yellow isoquinoline alkaloid isolated from many medicinal plants belonging to a wide range of families, as a medicinal compound. It shows antimicrobial activity against Gram-positive and -negative bacteria and other microorganisms, 1) whereas it exhibits low toxicity to human cells. Hence, berberine has been used conventionally as an antidiarrheic, bitter stomachic, and antimalarial.
2) In recent years, many more divergent biological activities have been reported for berberine and related protoberberine alkaloids, e.g., inhibitory effects against lipoxygenase, 3) reverse transcriptase, 4) cyclooxygenase-2 playing a key role in colon tumorigenesis, 5) ion transport in human colonic epithelia, 6 ,7) c-Ki-ras2 proto-oncogene expression, 8) catecholamine biosynthesis, 9) and DNA and protein synthesis in Leishmania.
10) In addition, further physiological effects, such as antihypertensive, 11) prolongation of cardiac action-potential duration, 12) vasodilatory effects in rat mesenteric artery, 13) and aortic relaxation 14) have been also found for berberine and its derivatives.
This alkaloid possesses one methylene dioxy and two methoxy residues on its aromatic ring structure which contains a quaternary nitrogen atom in a six-membered ring that gives a stable positive charge, by which this compound shows moderate hydrophobicity. These are advantageous properties for a transport substrate of multidrug resistance pumps, such as multidrug resistance protein 1 (MDR1/P-glycoprotein), discovered in human cancer cells. 15) Indeed, the synergistic interaction of berberine with a bacterial multidrug resistance pump has recently been reported. 16) In human cancer cells, berberine treatment up-regulated mdr1 gene expression and also modulated the function of MDR1. 17) Berberine also functioned as a reversal agent of MDR1 18) and slightly activated its ATPase activity. 19) High expression of MDR1 or multidrug resistance-associated protein 1 (MRP1) in CCRF-CEM cell lines conferred high resistance to berberine in human cells. 20) These reports suggest that human MDR1 or MRP1 effluxes berberine as a substrate, which contributes, at least in part, to a decrease in the berberine toxicity in human cells, but it remains unclear whether these transporters can transport berberine directly. In this paper, we show that human MDR1 and MRP1 efflux berberine in an ATP-dependent manner by quantification of berberine fluorescence in KB cells. This efflux activity was inhibited by typical inhibitors of MDR1, e.g., verapamil, vinblastine, and cyclosporine A.
Human cultured cells KB3-1 were propagated in Dulbecco's modified Eagle's medium with 10% fetal y To whom correspondence should be addressed. Fax: +81-774-38-3623; E-mail: yazaki@rish.kyoto-u.ac.jp Abbreviations: ABC, ATP-binding cassette; HBSS, Hanks Buffered Saline Solution; MDR, multidrug resistance protein; MRP, multidrug resistance-associated protein Biosci. Biotechnol. Biochem., 71 (1), [242] [243] [244] [245] 2007 Note bovine serum under 5% CO 2 at 37 C. KB/MDR1 or KB/MRP1 cells were stably transfected with the MDR1 or MRP1 gene, as described previously, 21, 22) and were maintained in the presence of 30 ng/ml vinblastine and 40 ng/ml adriamycin respectively. First we compared the berberine fluorescence accumulated in KB/MDR1, in which this ABC transporter was highly expressed, and the control, KB3-1. KB/MDR1 cells and control KB3-1 cells grown on glass cover slips in 3.5-cm dishes (Meridian P35GC) were incubated in HBSS (Hanks Buffered Saline Solution) containing 0.1% glucose and berberine or rhodamine 123, a typical substrate of human MDR1 used as a positive control, washed thoroughly, and then observed under a fluorescence microscope (Zeiss Axiovert 100). Clear accumulation of rhodamine 123 (Fig. 1A , B) or berberine (Fig. 1C, D ) in KB3-1 cells was observed, whereas these fluorescent compounds scarcely accumulated in KB/MDR1 cells. In the presence of verapamil, a competitive inhibitor of human MDR1, the accumulation of berberine in KB/ MDR1 cells was reversed as much as in KB3-1 cells (Fig. 1C) . The accumulation level was quantitatively monitored with an Attofluor digital fluorescence imaging microscope (Fig. 1B, D) . Fluorescence images were collected with an intensified CCD video camera (Attofluor, Atto Instruments). Images were digitized and stored every 1 and 5 min after the addition of berberine. Fluorescence of berberine (excitation at 430 nm and emission at 550 nm) in individual cells was analyzed using an image-processing system (Ratiovision, Atto Instruments, Rockville, MD). These results suggest that the reduced accumulation of berberine was due to the efflux of this alkaloid from cells by human MDR1 in a manner similar to rhodamine 123.
Human MRP1 also shows efflux transport activity for plant alkaloids, as in human MDR1. 23) To investigate whether MRP1 can also recognize berberine as its substrate, berberine accumulation in KB/MRP1 cells was quantitatively monitored and compared to KB3-1 cells. The accumulation of berberine in KB/MRP1 cells was also lower than in KB3-1 cells (Fig. 2) . Although MRP1 exhibited a preference for organic anions, positively charged berberine also appears to be recognized as a substrate of human MRP1 as MDR1. Since another plant alkaloid, vincristine, has been reported to be co-transported with reduced GSH by human MRP1, 23) berberine might also be co-transported in a similar manner. Other MRP members capable of transporting certain anti-cancer alkaloids may also recognize berberine as their substrate, since overlapping substrate specificity is known among them.
23) The driving force of transport by both MDR1 and MRP1 is the energy of ATP hydrolysis. By incubating cells in ATP depletion medium (HBSS containing 10 mM sodium azide and 4 mM 2-deoxyglucose), berberine accumulation in both MDR1 and MRP1 transformants was as high as in the control cells, which strongly suggests that berberine was effluxed by these ABC transporters in an ATP-dependent manner (Fig. 2) . In KB3-1 cells, berberine accumulation was not affected by ATP depletion.
Next we examined the effects of several typical inhibitors of human MDR1 on berberine efflux. Verapamil, vinblastine, and cyclosporine A strongly inhibited berberine efflux by MDR1, resulting in higher berberine accumulation in KB/MDR1 cells (Fig. 3) . These compounds also showed similar inhibitory effects on berberine efflux by MRP1, whereas the increased rate of berberine accumulation relative to the control was less than that of KB/MDR1 cells. This might be because these compounds had a low inhibitory effect on MRP1 as compared to MDR1. These cellular transport data indicate that MDR1 and MRP1 recognized berberine as the substrate and effluxed it. A reduced sensitivity to berberine in MDR1-or MRP1-overexpressing human cells has been reported, 20) and the reduced accumulation of berberine by extruding it is a logical explanation for low berberine toxicity. Experiments were repeated at least three times to confirm reproducibility. Statistical analysis was done by Student's t-test. An asterisk indicates statistically significant difference as compared to control ( Ã , P < 0:05; ÃÃ , P < 0:01). Control, no inhibitor; +Ver, verapamil (100 mM); +Vbl, vinblastine (100 mM); +CSA, cyclosporine A (50 mM).
